Skip to content

Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients

Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00780884
Enrollment
21
Registered
2008-10-28
Start date
2008-04-30
Completion date
2009-04-30
Last updated
2015-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizoaffective, Schizophrenia

Keywords

acupuncture, schizophrenia, insomnia

Brief summary

Insomnia, a common feature of schizophrenia, has serious consequences for daytime functioning and quality of life. Although insomnia is most often treated with medication, a growing number of studies have demonstrated the efficiency of a variety of relaxation techniques, cognitive behavioral therapies and alternative medicine procedures. Acupuncture is among the oldest healing practices in the world. Part of traditional Chinese medicine, acupuncture aims to restore and maintain health through the stimulation of specific points on the body. Previous studies have demonstrated that acupuncture has a positive influence on a number of diseases and disorders, among them Depression, Chronic Pain and Sleep Disorders. Hence, the aim of the present study is to examine the effects of acupuncture as a treatment for insomnia in schizophrenic patients.The study begins with a 7-day, running-in, no-treatment period, followes by an 8-week experimental period. During the experimental period, subjects receive acupuncture treatments twice a week. During the first week of the study (no-treatment period) and the last week of the experimental period, subjects' sleep is monitored with a wrist actigraph, and subjects complete a wide spectrum of questionnaires.

Interventions

DEVICEacupuncture

16 sessions of acupuncture treatment, twice a week.

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. schizophrenia or schizoaffective disorder - diagnosed according DSM-4. 2. capability to sign inform consent.

Exclusion criteria

1. unstable physical illness 2. drug or alchohol abuse or dependence

Design outcomes

Primary

MeasureTime frame
sleep efficiency8 weeks

Secondary

MeasureTime frame
anxiety and depression levels8 weeks

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026